[1] |
HUNTER C A,SIBLEY L D.Modulation of innate immunity by Toxoplasma gondii virulence effectors[J]. Nature Review Microbiology,2012,10(11):766-778.
|
[2] |
FLEGR J,PRANDOTA J,SOVICKOVÁ M,et al.Toxoplasmosis——A global threat.Correlation of latent toxoplasmosis with specific disease burden in a set of 88 countries[J]. PLoS One,2014,9(3):e90203.
|
[3] |
MONTAZERI M,SHARIF M,SARVI S,et al.A systematic review of in vitro and in vivo activities of anti- Toxoplasma drugs and compounds (2006-2016)[J]. Frontiers in Microbiology,2017,8:25.
|
[4] |
HOTEZ P J.Neglected parasitic infections and poverty in the United States[J]. PLoS Neglected Tropical Diseases,2014,8(9):e3012.
|
[5] |
ÉRICA S M,JULIO A U,WANDERLEY D S,et al.Anti proliferative activities of two novel quinuclidine inhibitors against Toxoplasma gondii tachyzoites in vitro[J]. Journal of Antimicrobial Chemotherapy,2006,58:59-65.
|
[6] |
AHMADPOUR E,DARYANI A,SHARIF M,et al.Toxoplasmosis in immunocompromised patients in Iran:A systematic review and meta-analysis[J]. The Journal of Infection in Developing Countries,2014,8(12):1503-1510.
|
[7] |
LIM S S Y,OTHMAN R Y.Recent advances in Toxoplasma gondii mmunotherapeutics[J]. Korean Journal of Parasitology,2014,52(6):581-593.
|
[8] |
ZHANG N Z,WANG M,XU Y,et al.Recent advances in developing vaccines against Toxoplasma gondii:An update[J]. Expert Review of Vaccines,2015,14(12):1609-1621.
|
[9] |
BESSIÈRES M H,BERREBI A,CASSAING S,et al.Diagnosis of congenital toxoplasmosis:Prenatal and neonatal evaluation of methods used in toulouse university hospital and incidence of congenital toxoplasmosis[J]. Memórias do Instituto Oswaldo Cruz,2009,104(2):389-392.
|
[10] |
HABIB F A.Post-treatment assessment of acute Toxoplasma infection during pregnancy[J]. Journal of Obstetrics and Gynaecology Research,2008,28:593-595.
|
[11] |
HELIEH S O.Maternal and congenital toxoplasmosis,currently available and novel therapies in horizon[J]. Frontiers in Microbiology,2014,5:385.
|
[12] |
SERGIO O A,MARIANA M,PABLO C E.A review of recent patents on the protozoan parasite HSP90 as a drug target[J]. Recent Patents on Biotechnology,2013,7(1):2-8.
|
[13] |
XUE J X,JIANG W,CHEN Y J,et al.Thioredoxin reductase from Toxoplasma gondii:An essential virulence effector with antioxidant function[J]. FASEB Journal,2017,31(10):4447-4457.
|
[14] |
ALOMAR M L,RASSE-SURIANI F A,GANUZA A,et al. In vitro evaluation of β-carboline alkaloids as potential anti- Toxoplasma agents[J]. BMC Research Notes,2013,6(1):193.
|
[15] |
LIMA L P O D,SEABRA S H,CARNEIRO H,et al.Effect of 3-bromopyruvate and atovaquone on infection during in vitro interaction of Toxoplasma gondii and LLC-MK2 cells[J]. Antimicrob Agents Chemother,2015,59(9):5239-5249.
|
[16] |
ANDRADE R M,CHAPARRO J D,CAPPARELLI E,et al.Auranofin is highly efficacious against Toxoplasma gondii in vitro and in an in vivo experimental model of acute toxoplasmosis[J]. PLoS Neglected Tropical Diseases,2014,8(7):e2973.
|
[17] |
蒋蔚,陈永军,张花景,等. 磺胺氯吡嗪钠中药复方对小鼠体内抗弓形虫疗效的观察[J].畜牧兽医学报,2013,44(22):2022-2028. JIANG W,CHEN Y J,ZHANG H J,et al.Treatment effects of sulfachloropyrazine-sodium with scutellaria baicalensis and glucurrhiza against acute murine toxoplasmosis[J]. Acta Veterinaria et Zootechnica Sinica,2013,44(22):2022-2028.(in Chinese)
|
[18] |
龚国华,侯加法,蒋蔚,等.七种药物体内外抗弓形虫效果分析[J].畜牧与兽医,2011,43(7):58-61. GONG G H,HOU J F,JIANG W,et al.Anti- Toxoplasma effects of seven drugs in vitro and in vivo[J]. Animal Husbandry & Veterinary Medicine,2011,43(7):58-61.(in Chinese)
|
[19] |
BISHAYEE A,RAO D V,BOUCHET L G,et al.Protection by DMSO against cell death caused by intracellularly localized iodine-125,iodine-131 and polonium-210[J]. Radiation Research,2000,153(4):416-427.
|
[20] |
杨远和,BERNSTEIN I A.二甲基亚砜对人表皮的核酸和蛋白质合成的影响[J].中华劳动卫生职业病杂志,1994,12(1):32-34. YANG Y H,BERNSTEIN I A.Effects of dimethyl sulfoxide on DNA,RNA and protein syntheses of human epedermis[J]. Chinese Journal of Industrial Hygiene and Dccupational Diseases,1994,12(1):32-34.(in Chinese)
|
[21] |
张鹏,张娜,景明.MTT法评价二甲基亚砜对小鼠淋巴瘤细胞增殖率的影响[J].生物化工,2017,3(2):53-54. ZHANG P,ZHANG N,JING M.Evaluation of the effect of DMSO on the proliferation of mouse lymphoma cells by MTT[J]. Biological Chemical Engineering,2017,3(2):53-54.(in Chinese)
|
[22] |
宋凤艳.肿瘤细胞ECA109对甲醇等4种有机溶剂耐受剂量分析[J].井冈山大学学报(自然科学版),2014,5:88-93. SONG F Y.Tolerance dose analysis of cancer cell ECA109 to four organic solvents as methanol/ethanol/acetone/glycerol[J]. Journal of Jinggangshan University (Natural Science Edition),2014,5:88-93.(in Chinese)
|
[23] |
钟立霖,朱静,吴晓芸,等.乙醇及其代谢产物对心肌祖细胞的毒性及H3K9表突变作用[J].第三军医大学学报,2010,32(14):1491-1494. ZHONG L L,ZHU J,WU X Y,et al.Ethanol and its metabolites induce cytotoxicity and H3K9 epimutation in cardiac progenitor cells[J]. Acta Academiae Medicinae Militaris Tertiae,2010,32(14):1491-1494.(in Chinese)
|
[24] |
孙佩君,刘健烽,冯三畏,等.二甲基甲酰胺对V79细胞的毒性作用[J].环境与职业医学,2013,30(4):268-270. SUN P J,LIU J F,FENG S W,et al.Toxic effects of N,N-dimethylformamide on V79 cells in vitro[J]. Journal of Environmental & Occupational Medicine,2013,30(4):268-270.(in Chinese)
|
[25] |
向梅,杨永坚,王取男,等.二甲基甲酰胺对心肌细胞的毒性作用[J].中华疾病控制杂志,2013,17(7):581-584. XIANG M,YANG Y J,WANG Q N,et al.The cell toxicity of myocardial cells which exposed to dimethylformamide (DMF)[J]. Chinese Journal of Disease Control & Prevention,2013,17(7):581-584.(in Chinese)
|